+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase Not Applicable
Age: 18Years +
All Genders
ID07817147

Feasibility Study of a Novel Endoscopic Ultrasound-Guided Microwave Ablation Device for Advanced Pancreatic and Liver Cancer

Led by Banner Health · Updated on 2026-09-14

75

Participants Needed

7

Research Sites

26 weeks

Total Duration

AI-Summary

What This Trial Is About

Researchers are evaluating the use of a new endoscopic ultrasound-guided microwave ablation MWA device in patients with locally advanced, unresectable, or metastatic cancers such as pancreatic and liver cancer. The study aims to assess the overall success of energy delivery during treatment and to explore the safety and antitumor effects of the device. This feasibility study will provide preliminary data to guide future clinical trials and potential clinical use for difficult-to-treat tumors. Participants will receive treatment using the Creos MicroBlate Fine device guided by endoscopic ultrasound EUS. This open-label study involves a single group where all eligible participants receive the MWA procedure targeting tumors accessible via EUS through the gastric wall, such as those in the pancreas or liver. Tumors must be at least 1 cm in diameter. The treatment phase lasts up to 9 weeks from the first MWA procedure. During the study, participants will be monitored through scheduled visits for safety and effectiveness assessments up to 52 weeks after treatment begins. Researchers will evaluate procedural and clinical safety, treatment tolerability, and early antitumor effects by measuring tumor size changes and using RECIST criteria at 6 months. The overall study participation lasts up to approximately one year, including follow-up visits to track long-term outcomes and safety.

CONDITIONS

Brief Title

CREO - Microwave Ablation Feasibility Study

Research Team

N

Neil Sharma, MD

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here